| Financial Year |
March 31 2023 |
| Monetary Funds |
582,670,934.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
369,778.00 |
| Accounts Receivable |
624,646,913.36 |
| Advances to Suppliers |
2,211,305.85 |
| Other Receivables |
25,895,160.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
142,673,119.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,297,297.06 |
| Total Current Assets |
1,409,206,738.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
325,281,813.04 |
| Investment Properties |
6,924,362.03 |
| Fixed Assetes |
120,652,757.99 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,183,806.69 |
| R&D expenses |
35,948,244.32 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,575,923.17 |
| Deferred Income Tax Assets |
74,534,252.72 |
| Other Non-Current Assets |
89,130.65 |
| Sub-Total of Non-Current Assets |
668,320,119.69 |
| Total Assets |
2,077,526,857.85 |
| Short-Term Loans |
393,943,830.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
178,000,000.00 |
| Accounts Payable |
72,889,397.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
101,935,624.35 |
| Taxes Payable |
14,388,584.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,502,370.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,588,057.75 |
| Other Current Liabilities |
3,815,476.74 |
| Sub-Total of Current Liabilities |
814,432,538.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
240,034.08 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,539,097.07 |
| Total Liabilities |
822,971,636.04 |
| Paid-In Capital(Or Share Stock) |
164,183,709.00 |
| Capital Surplus |
864,376,732.58 |
| Surplus Reserve |
46,327,927.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
176,415,215.77 |
| Minority Stockholder's Interest |
3,695,461.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,250,859,759.84 |
| Owner's Equity（Stockholder's Equity） |
1,254,555,221.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,077,526,857.85 |
